Effect of anesthesia in APGAR score for a newbor
Not Applicable
Completed
- Conditions
- Apgar.
- Registration Number
- IRCT20230703058656N2
- Lead Sponsor
- Rafsanjan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 90
Inclusion Criteria
Pregnant women candidate for elective cesarean section
Infants with gestational age between 37-39 weeks
Exclusion Criteria
Infant born from mothers with the underlying disease like diabetes, hypertension and ...
Infant born from mothers with clinical sign of difficult intubation
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie APGAR score differences between spinal and general anesthesia using thiopental and ketamine in newborns?
How does spinal anesthesia compare to general anesthesia with thiopental and ketamine in improving APGAR scores for term and preterm infants?
Which maternal or neonatal biomarkers predict APGAR outcomes in IRCT20230703058656N2 anesthesia trial?
What are the safety profiles and adverse event management strategies for thiopental and ketamine in IRCT20230703058656N2?
Are there alternative anesthetic combinations or drugs that could enhance APGAR scores compared to thiopental and ketamine in this trial?